Racial disparities in non-recommendation of adjuvant chemotherapy in stage II-III ovarian cancer. Matthews BJ, Qureshi MM, Fiascone SJ, Nitschmann CC, et al. Gynecol Oncol 2021 Nov 13. pii: S0090-8258(21)01553.

Read + Share

Amedeo Smart

Independent Medical Education

Matthews BJ, Qureshi MM, Fiascone SJ, Nitschmann CC, et al. Racial disparities in non-recommendation of adjuvant chemotherapy in stage II-III ovarian cancer. Gynecol Oncol 2021 Nov 13. pii: S0090-8258(21)01553.
PMID: 34785030